歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

未开盘 10-15 16:08:35

5.785

-0.095

-1.62%

最高6.245	最低5.400	成交量578.00万
今开5.880	昨收5.880	日振幅14.37%
总市值60.86亿	流通市值60.86亿	总股本10.52亿
成交额3,408万	换手率0.55%	流通股本10.52亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":5.785,"timestamp":1792051715006,"preClose":5.88,"halted":0,"volume":5780000,"delay":0,"changeRate":-0.016156462585033973,"floatShares":1052000000,"shares":1052000000,"eps":-0.3701,"marketStatus":"未开盘","change":-0.095,"latestTime":"10-15 16:08:35","open":5.88,"high":6.245,"low":5.4,"amount":34082849,"amplitude":0.143707,"askPrice":5.79,"askSize":3000,"bidPrice":5.785,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.675455,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792114200000},"marketStatusCode":0,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":5.88,"openAndCloseTimeList":[[1792027800000,1792036800000],[1792040400000,1792051200000]],"volumeRatio":1.625879,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672/wiki","defaultTab":"wiki","newsList":[{"id":"1166794805","title":"歌礼制药-B回购150万股，涉资约883.07万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166794805","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166794805?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:42","pubTimestamp":1792060978,"startTime":"0","endTime":"0","summary":"歌礼制药-B于2026年10月15日发布公告，公司当日于香港联交所场内回购普通股150万股，占公司已发行股本的约0.1426%。此次回购价格介乎每股5.645港元至6.23港元，合计支付约883.07万港元。公告显示，本次回购完成后，公司已发行股本仍为1,052,202,859股，库存股为5,784,210股，总股本为1,057,987,069股。公司在公告中确认此次回购符合香港联交所证券上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"歌礼制药-B回购150万股，涉资约883.07万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675857655","title":"歌礼制药-B(01672.HK)10月15日斥资883.07万港元回购150万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675857655","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675857655?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:39","pubTimestamp":1792060782,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1574","BK1191","01477","01672","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675934347","title":"歌礼制药-B(01672.HK)10月14日斥资122.15万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675934347","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675934347?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:33","pubTimestamp":1791973988,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01672","BK1191","01477","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183537009","title":"歌礼制药-B回购20万股，涉资约122.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183537009","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183537009?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:31","pubTimestamp":1791973877,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年10月14日发布公告，披露当日于香港联交所回购20万股普通股，占公司已发行股本约0.019%。本次回购价格介乎每股港币5.88元至6.715元，合计付出约122.15万港元。公告显示，本次股份回购完成后，公司已发行股份数维持1,052,202,859股，库藏股数量为5,784,210股。公司此前已于2026年6月29日通过购回授权，授权购回股份总数为106,137,084股。公司在公告中确认，已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由公司秘书钟明辉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B回购20万股，涉资约122.15万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174316641","title":"歌礼制药-B：10月13日回购20万股，斥资约134.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174316641","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174316641?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:32","pubTimestamp":1791883943,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年10月13日发布翌日披露报表，公告了已发行股本及股份回购情况。公司于同日于香港联交所场内回购普通股共200,000股，占当前已发行股本约0.019%。回购每股最高价为6.85港元，最低价为6.53港元，合计支付价款1,342,815港元。回购完成后，公司已发行股本仍为1,052,202,859股，库存股份为5,784,210股，合计1,057,987,069股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B：10月13日回购20万股，斥资约134.28万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157830362","title":"港股创新药概念股集体走低，华昊中天医药-B跌超11%、金斯瑞生物科技跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157830362","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157830362?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:38","pubTimestamp":1791855517,"startTime":"0","endTime":"0","summary":"10月13日，港股创新药概念股集体走低，$华昊中天医药-B(02563)$跌超11%，$金斯瑞生物科技(01548)$跌超10%，$药明合联(02268)$、$晶泰控股(02228)$跌超4%，$药明生物(02269)$、$歌礼制药-B(01672)$跌超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU2039709279.SGD","09939","BK1617","LU0128526141.USD","LU0456827905.SGD","LU0359201612.USD","LU0051755006.USD","LU0819121731.USD","LU0456846285.SGD","LU0823426308.USD","LU0708995583.HKD","SG9999002463.SGD","LU0327786744.USD","HK0000306701.USD","LU0516422366.SGD","BK1515","LU0979878070.USD","LU0244354667.USD","LU2488822045.USD","BK1161","LU0856984785.SGD","HK0000320223.HKD","LU0052750758.USD","LU0828237510.HKD","LU1831875114.USD","IE00B0JY6N72.USD","02268","LU0516423174.USD","LU0708995153.HKD","SG9999002562.SGD","LU0359202008.SGD","LU1188198961.HKD","LU0572944931.SGD","LU1880383366.USD","02563","LU0211977185.USD","LU0228659784.USD","LU1242518931.SGD","LU1720050803.USD","VXUS","LU1242518857.USD","LU0320764243.SGD","LU0516422952.EUR","01548","BK4588","LNGR","KCAI","LU0128522744.USD","LU0516422440.USD","IBBQ","BK1583","LU0140636845.USD","LU1794554557.SGD","LU0043850808.USD","BK4585","LU0561508036.HKD","KURE","02269","LU0029874905.USD","LU2778985437.USD","LU3063872942.SGD","BK1576","LU1688375341.USD","HK0000306685.HKD","LU0326950275.SGD","LU0029874061.USD","LU0634319403.HKD","LU0516423091.SGD","02228","LU0348735423.USD","LU0307460666.USD","BK1610","LU0540923850.HKD","LU0348825331.USD","BK1589","HK0000320264.USD","LU0823426480.USD","01477","LU0463099449.HKD","LU0181495838.USD","LU2476274720.SGD","BK1141","LU0348827113.USD","MEDX","01672","LU0417516738.SGD","06978","LU0417516902.SGD","BK1574","BK1521","LU0320764599.SGD","SG9999014674.SGD","LU2476274308.USD","LU0588546209.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103365265","title":"歌礼制药-B10月12日回购20万股，耗资约137.03万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103365265","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103365265?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:55","pubTimestamp":1791802546,"startTime":"0","endTime":"0","summary":"2026年10月12日，歌礼制药有限公司发布翌日披露报表，公布在香港联交所进行了股份回购。本次公司回购普通股股份20万股，约占回购前已发行股本的0.019%。回购价格介乎每股6.68港元至7.09港元，合计支付1,370,265港元，折合约137.03万港元。公告显示，此次回购基于公司于2026年6月29日获得的购回授权。该授权可回购的股份总数为106,137,084股，截至本次回购后，歌礼制药-B已累计购回2,345,000股，占购回授权决议获通过当日已发行股份数目的0.2209%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"歌礼制药-B10月12日回购20万股，耗资约137.03万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674720871","title":"歌礼制药-B(01672)10月12日耗资约137.03万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674720871","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674720871?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:55","pubTimestamp":1791802538,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B(01672)公布，2026年10月12日耗资约137.03万港元回购20万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1506049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01477","BK1515","BK1574","01672","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673896025","title":"港股异动 | 创新药概念股午后跌幅扩大 歌礼制药-B(01672.HK)跌超10% 信达生物(01801.HK)跌近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673896025","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673896025?lang=zh_cn&edition=full","pubTime":"2026-10-08 14:01","pubTimestamp":1791439309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1589","LU0607220059.USD","BK1191","01801","LU2328871848.SGD","LU2488822045.USD","LU1188198961.HKD","06978","KURE","LU0463099449.HKD","LU2097828557.USD","LU2097828631.EUR","HK0000165453.HKD","LU2097828474.EUR","BK1574","BK1583","BK1515","LU0244354667.USD","LU0326950275.SGD","LU1969619763.USD","01672","BK1161","01477","LU2242644610.SGD","LU0149534421.HKD","LU2097828714.EUR","LU0502904849.HKD","LU1831875114.USD","LU0455707207.USD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190144897","title":"港股直击｜医药股及医药外包股重挫，金斯瑞生物科技大跌 14%，康希诺生物、歌礼制药跌 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1190144897","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190144897?lang=zh_cn&edition=full","pubTime":"2026-10-07 09:38","pubTimestamp":1791337108,"startTime":"0","endTime":"0","summary":"医药股及医药外包股重挫，金斯瑞生物科技大跌 14%，昭衍新药跌 10%，康希诺生物、歌礼制药、再鼎医药、和铂医药跌 6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01548","06127","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199202609","title":"歌礼制药-B更新2026年9月股份变动月报表，新增期权行使218,014股","url":"https://stock-news.laohu8.com/highlight/detail?id=1199202609","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199202609?lang=zh_cn&edition=full","pubTime":"2026-10-06 17:16","pubTimestamp":1791278178,"startTime":"0","endTime":"0","summary":"歌礼制药有限公司于2026年10月6日发布截至2026年9月30日的股份变动月报表。报告期内，公司法定/注册股本保持不变，仍为7,000,000,000股普通股，合计USD 700,000。月报显示，普通股已发行股份于期初为1,051,984,845股，期内因员工期权行使新增发行218,014股，期末增至1,052,202,859股。库存股份数量期初与期末均为5,784,210股，合计已发行及库存股份总数从期初的1,057,769,055股增至1,057,987,069股。期权与激励计划方面，2019年6月6日通过的购股权计划在本月行使了218,014股，合计获得资金HKD 477,345。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673031677","title":"歌礼制药-B午后涨近11% 减重复方制剂ASC36_35FDC临床前数据公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2673031677","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673031677?lang=zh_cn&edition=full","pubTime":"2026-10-06 14:33","pubTimestamp":1791268380,"startTime":"0","endTime":"0","summary":"模拟交易客户端歌礼制药-B午后涨近11%。截至发稿，股价上涨10.80%，现报9.03港元，成交额1046.08万港元。歌礼制药宣布，其减重复方制剂ASC36_35FDC的关键临床前数据在第62届欧洲糖尿病研究协会年会上以简短口头讨论形式发布。公开资料显示，ASC36_35FDC是利用歌礼专有的基于结构的AI辅助药物发现和超长效药物开发平台 技术自主开发的复方疗法。近期，公司宣布在获得FDA批准的IND后，已启动ASC36口服片用于治疗肥胖症的美国I期研究。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-10-06/doc-iniuhiti5735024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1515","01672","01477","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673561031","title":"港股异动 | 歌礼制药-B(01672.HK)午后涨超10% 减重复方制剂ASC36_35FDC临床前数据公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2673561031","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673561031?lang=zh_cn&edition=full","pubTime":"2026-10-06 14:27","pubTimestamp":1791268020,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1161","01672","BK1574","BK1515","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673803803","title":"港股异动 | 创新药概念股涨势延续 美银指近期三项重磅合作强化板块动能 ESMO有望带来密集催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2673803803","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673803803?lang=zh_cn&edition=full","pubTime":"2026-10-06 10:05","pubTimestamp":1791252333,"startTime":"0","endTime":"0","summary":"美银证券发布研报称，中国医药/生物科技近期三项合作强化板块动能渤海证券表示，近期AI制药催化密集，行业焦点逐步从模型能力转向湿实验验证效率等方面，建议关注AI制药相关基因合成、蛋白表达、试剂耗材、动物模型及临床试验等细分赛道的投资机遇。同时，2026年ESMO年会即将召开，优异临床数据有望读出，带来板块密集催化，建议关注创新药、CXO及生命科学上游产业链等的投资机遇。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","LU2399975544.HKD","BK1589","KURE","BK4585","MEDX","LU0417516738.SGD","IE00BPRC5H50.USD","LU2476274720.SGD","BK1515","06185","LU0348827113.USD","IE00BZ08YR35.GBP","LU2778985437.USD","LU0348767384.USD","IBBQ","LNGR","LU0348735423.USD","LU0634319403.HKD","LU0348783233.USD","KCAI","HK0000165453.HKD","LU0417516902.SGD","IE00BZ08YS42.EUR","159992","BK1574","LU0348766576.USD","LU0348825331.USD","01177","BK4588","LU0561508036.HKD","BK1161","01672","IE00B5MMRT66.SGD","LU2476274308.USD","LU0348784397.USD","LU2488822045.USD","LU1961090484.USD","LU1720050803.USD","LU0417516571.SGD","IE00B543WZ88.USD","09926","LU0540923850.HKD","BK1191","VXUS","IE00BZ08YT58.USD","LU1794554557.SGD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673734038","title":"创新药概念普升 歌礼制药-B（01672）涨11.78%、再鼎医药（09688）涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673734038","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673734038?lang=zh_cn&edition=full","pubTime":"2026-10-06 09:54","pubTimestamp":1791251688,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念普涨，截至发稿，歌礼制药-B 涨11.78%，再鼎医药涨6.55%，金斯瑞生物科技涨5.30%，晶泰控股涨4.40%，中国生物制药涨3.96%，三生制药涨3.41%，药明生物涨3.16%，康方生物涨3.11%，云顶新耀涨3.10%，四环医药涨2.82%。2026ESMO已公布LBA标题，29项LBA的试验药物由中国药企原研或参与开发，涉及约20家企业，其中5项进入主席研讨会。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993103","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","LU0708995153.HKD","BK4588","02228","LU0823426308.USD","MEDX","01952","LU0211977185.USD","LU0359201612.USD","BK1521","KURE","IE00BZ08YT58.USD","LU0516423091.SGD","LU0348784397.USD","LU0029874905.USD","09926","LU0348827113.USD","06978","159992","SG9999002463.SGD","IE00BPRC5H50.USD","BK1161","LU2476274308.USD","IBBQ","BK1574","LU2778985437.USD","BK1515","09688","BK1141","LU0320764243.SGD","LU0348735423.USD","HK0000306701.USD","BK4139","00460","LNGR","01530","ZLAB","LU0052750758.USD","LU0516422366.SGD","01672","02269","BK1191","01548","LU0029874061.USD","LU0417516902.SGD","01477","LU0348766576.USD","LU0140636845.USD","LU0320764599.SGD","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186757843","title":"港股异动 | 创新药概念股普涨，歌礼制药-B涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186757843","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186757843?lang=zh_cn&edition=full","pubTime":"2026-10-06 09:54","pubTimestamp":1791251648,"startTime":"0","endTime":"0","summary":"10月6日，港股创新药概念普涨，$歌礼制药-B(01672)$涨超12%，$金斯瑞生物科技(01548)$涨超5%，$中国生物制药(01177)$涨超4%，$三生制药(01530)$、$药明生物(02269)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","LU0856984785.SGD","IE00BZ08YR35.GBP","HK0000306685.HKD","KCAI","LU0634319403.HKD","LU2476274720.SGD","LU0516422366.SGD","LU0516422952.EUR","LU1688375341.USD","BK1610","BK1191","LU0128526141.USD","LU0572944931.SGD","BK1515","LU0029874061.USD","LU0326950275.SGD","LU0320764243.SGD","LU0348825331.USD","HK0000306701.USD","LU1242518857.USD","LU0052750758.USD","LU0540923850.HKD","LU0359201612.USD","BK1589","LU1242518931.SGD","SG9999002463.SGD","LU0456846285.SGD","BK1576","BK4588","LU0588546209.SGD","IE00BZ08YT58.USD","LU0359202008.SGD","LU0417516902.SGD","SG9999002562.SGD","LU0211977185.USD","HK0000320264.USD","LU2778985437.USD","LU0561508036.HKD","BK1574","HK0000320223.HKD","BK1583","LU0823426480.USD","VXUS","LU0823426308.USD","LU0043850808.USD","KURE","LU3063872942.SGD","LU0320764599.SGD","BK4585","BK1593","BK1521","IE00B0JY6N72.USD","LU0307460666.USD","LU1794554557.SGD","LU0456827905.SGD","LU0516422440.USD","HK0000165453.HKD","LU0051755006.USD","LU1880383366.USD","LU0029874905.USD","LU0516423174.USD","LU2039709279.SGD","01672","LNGR","LU0348735423.USD","LU0708995583.HKD","BK1141","LU0039217434.USD","LU0819121731.USD","159992","LU0181495838.USD","LU1720050803.USD","IE00BZ08YS42.EUR","MEDX","LU0348827113.USD","LU2476274308.USD","IBBQ","LU0417516738.SGD","LU0708995153.HKD","BK1161","LU0516423091.SGD","LU0128522744.USD","LU0140636845.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713832","title":"歌礼制药-B(01672)：ASC36_35FDC临床前研究亮相EASD 2026，展现每月一次至每季度一次给药潜力与强劲的减重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713832","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672713832?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:55","pubTimestamp":1790931359,"startTime":"0","endTime":"0","summary":"ASC36_35FDC是 ASC36与ASC35的每月一次至每季度一次固定剂量复方注射剂。此外，公司已开发ASC36_35FDC的每周一次口服片剂。在DIO大鼠模型中，ASC36_35FDC以5 nmol/kg_8 nmol/kg的剂量，每2日给药1次，共给药7次，展现出强劲的减重效果。相同给药方案下，第14天时， eloralintide╱替尔泊肽复方制剂组体重下降12.5%，MET-233i/tirzepatide复方制剂组下降16.8%，ASC36_35FDC组下降24.8%，减重效果分别相对提升98%和 47%。同时，ASC36_35FDC组的累积食物摄入量也显著低于上述两个对照组。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1191","BK1161","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149659399","title":"歌礼制药-B（01672）公布ASC36_35FDC关键临床前数据 14天减重达24.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149659399","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149659399?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:55","pubTimestamp":1790931351,"startTime":"0","endTime":"0","summary":"2026年10月2日，歌礼制药-B发布自愿性公告称，在2026年9月28日至10月2日于意大利米兰举行的第62届欧洲糖尿病研究协会年会上，公司展示了固定剂量复方注射剂ASC36_35FDC的最新临床前研究结果。该复方由胰淀素受体激动剂ASC36和GLP-1R/GIPR激动剂ASC35组成，目标给药频次为每月一次至每季度一次。ASC36_35FDC的减重效果分别较上述两组提升98%和47%。歌礼制药-B提醒，根据香港联交所证券上市规则第18A.05条，公司无法保证最终能成功将ASC36_35FDC开发、销售及商业化。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671652022","title":"歌礼制药-B(01672)宣布同类首创和同类最佳的口服小分子IL-17A抑制剂ASC50治疗斑块状银屑病在美国的28天概念验证临床研究取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2671652022","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671652022?lang=zh_cn&edition=full","pubTime":"2026-09-29 07:56","pubTimestamp":1790639809,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672)公布，ASC50在美国轻度至中度斑块状银屑病患者中开展的一项随机、双盲、安慰剂对照的28天概念验证临床试验取得积极结果。该I期研究旨在评估每日一次200毫克ASC50在轻度至中度斑块状银屑病患者中治疗28天后的安全性、疗效和药代动力学(NCT07024602)。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg17.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg17.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK1191","BK1515","BK1574","01672","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143824561","title":"歌礼制药-B（01672）披露ASC50治疗斑块状银屑病28天美国概念验证试验积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1143824561","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143824561?lang=zh_cn&edition=full","pubTime":"2026-09-29 07:56","pubTimestamp":1790639760,"startTime":"0","endTime":"0","summary":"2026年9月29日，歌礼制药-B发布自愿性公告称，其自主研发的口服小分子IL-17A抑制剂ASC50在美国开展的28天随机、双盲、安慰剂对照概念验证临床试验取得积极数据。公告显示，在每日一次口服200毫克、共28天治疗周期结束时，轻度至中度斑块状银屑病患者的银屑病面积和严重程度指数经安慰剂校正后下降48.9%。药代动力学方面，接受28天治疗的患者显示ASC50稳态消除半衰期为6.5天，为每周一次口服给药提供支持。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.2333},{"period":"1month","weight":-0.3529},{"period":"3month","weight":-0.3088},{"period":"6month","weight":-0.687},{"period":"1year","weight":-0.3942},{"period":"ytd","weight":-0.4921}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.0245},{"period":"3month","weight":-0.0203},{"period":"6month","weight":-0.0802},{"period":"1year","weight":-0.0713},{"period":"ytd","weight":-0.0612}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品研发、生产和销售的投资控股公司。该公司专注于病毒性疾病、非酒精性脂肪性肝炎（NASH）或原发性胆汁性胆管炎（PBC）及肿瘤领域。该公司的产品管线包括用于慢性乙肝功能性治愈的ASC22、用于呼吸道合胞病毒（RSV）的ASC10、用于人类免疫缺陷病毒（HIV）功能性治愈的ASC22、用於新冠肺炎的ASC10及ASC11、用於NASH的ASC41、用於PBC的ASC42、用于实体瘤的ASC61、用于中、重度痤疮的ASC40等。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.146882},{"month":2,"riseRate":0.75,"avgChangeRate":0.100059},{"month":3,"riseRate":0.375,"avgChangeRate":-0.044472},{"month":4,"riseRate":0.375,"avgChangeRate":-0.053142},{"month":5,"riseRate":0.375,"avgChangeRate":-0.01034},{"month":6,"riseRate":0.375,"avgChangeRate":-0.053675},{"month":7,"riseRate":0.5,"avgChangeRate":0.001982},{"month":8,"riseRate":0.375,"avgChangeRate":-0.008209},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.083211},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.054866},{"month":11,"riseRate":0.875,"avgChangeRate":0.185422},{"month":12,"riseRate":0.5,"avgChangeRate":0.087327}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}